At a glance
ClinicalIndex Comparison RecordN/ACompleted· 344 enrolled
Drug / intervention
Escitalopram +2 moredrug
Likely dose
Escitalopram 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Predictors of Antidepressant Treatment Response: The Emory CIDAR
In Brief
A clinical study evaluating Escitalopram, Duloxetine, and 1 other intervention for Depression. Completed, enrolled 344 participants across 2 sites.
Detailed Summary
This study will compare different treatments for depression in order to identify which factors predict effectiveness, and will include a companion study which investigates combining treatments and long term effectiveness.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2006
First PostedAug 2006
Primary CompletionApr 2015
TodayJul 2026
First PostedAug 4, 2006
Enrollment StartAug 1, 2006
Primary CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 8.7 yearsPosted 19.9 years ago
Interventions
Escitalopramdrug
Escitalopram 10 to 20 mg per day for 12 weeks
Duloxetinedrug
Duloxetine 30 to 60 mg per day for 12 weeks
Cognitive behavioral therapy (CBT)behavioral
CBT will include 16 one-hour sessions provided over 12 weeks.